The symposium was held October 27 at the 2016 Union World Conference on Lung Health in Liverpool, UK.

New Asia-Pacific coalition of TB activists launched.

>200 petition BRICS countries to triple funding for TB R&D to improve TB/AIDS and AMR response.

Civil society statement following the 47th Union World Conference on Lung Health, Liverpool

TB advocates urge Janssen and Otsuka to improve the affordability and availability of bedaquiline and delamanid.

Activists take over a session at the Union conference in Liverpool bringing awareness and attention to a number of broken promises by the Indian government to address a growing drug-resistant TB epidemic that burdens the nation.

International consortium publishes the first Primer on tuberculosis in Nature Reviews Disease Primers.

Treatment Action Group’s Report on Tuberculosis Research Funding Trends, 2005–2015: No Time to Lose shows that the world spent US$620.6 million on TB research and development in 2015, the lowest level of funding since 2008.

The petition will be delivered to the BRICS Ministers of Health on 14 November 2016, prior to their meeting in December in New Delhi.

The Global TB Programme and the Special Programme for Research and Training in Tropical Diseases at the World Health Organization launch a global database for active TB drug safety monitoring and management (aDSM). Countries are now invited to contribute data to the global database.